Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8347379, 7 pages
http://dx.doi.org/10.1155/2016/8347379
Research Article

Investigation of Vitamin D-Binding Protein Polymorphism Impact on Coronary Artery Disease and Relationship with Longevity: Own Data and a Review

1Laboratory of Cancerogenesis and Cancer Epidemiology, Scientific Research Center, National Cancer Institute, Santariskiu 1, LT-08660 Vilnius, Lithuania
2Department of Biolaw, Mykolas Romeris University, Ateities 21, LT-08303 Vilnius, Lithuania
3Department of Geriatrics, Medical Academy, Lithuanian University of Health Sciences, A. Mickevičiaus 9, LT-44307 Kaunas, Lithuania
4Radiation and Medical Oncology Clinics, National Cancer Institute, Santariskiu 1, LT-08660 Vilnius, Lithuania
5Oncosurgery Clinics, National Cancer Institute, Santariskiu 1, LT-08660 Vilnius, Lithuania
6Institute of Cardiology of the Medical Academy, Lithuanian University of Health Sciences, Sukileliu 17, LT-50161 Kaunas, Lithuania

Received 7 January 2016; Accepted 23 March 2016

Academic Editor: Zhongjian Xie

Copyright © 2016 Donatas Stakisaitis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. A. Spitsyn and D. V. Stakishaitis, “Interrelation of genetic dimorphism of ear wax and the level of apolipoproteins with atherogenesis and longevity in the Lithuanian population,” Genetika, vol. 29, no. 2, pp. 334–341, 1993. View at Google Scholar · View at Scopus
  2. D. V. Stakishaitis, S. M. Ianchauskene, L. I. Ivashkiavichene, and R. A. Priaiksha, “Atherogenesis and serum levels of apolipoprotein E,” Kardiologija, vol. 32, no. 6, pp. 14–16, 1992. View at Google Scholar
  3. D. Stakisaitis, V. Basys, and R. Benetis, “Does α-1-proteinase inhibitor play a protective role in coronary atherosclerosis?” Medical Science Monitor, vol. 7, no. 4, pp. 701–711, 2001. View at Google Scholar · View at Scopus
  4. D. Stakisaitis, A. Maksvytis, R. Benetis, and M. Viikmaa, “Coronary atherosclerosis and blood groups of AB0 system in women,” Medicina (Kaunas), vol. 38, supplement 2, pp. 230–235, 2002. View at Google Scholar
  5. F. R. Pérez-López, A. M. Fernández-Alonso, P. Mannella, and P. Chedraui, “Vitamin D, sunlight and longevity,” Minerva Endocrinologica, vol. 36, no. 3, pp. 257–266, 2011. View at Google Scholar · View at Scopus
  6. B. Schöttker, R. Jorde, A. Peasey et al., “Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States,” British Medical Journal, vol. 348, Article ID g3656, 2014. View at Publisher · View at Google Scholar
  7. M. Verdoia, A. Schaffer, L. Barbieri et al., “Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 25, no. 5, pp. 464–470, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Wang, Y.-J. Wang, J.-K. Zhan et al., “Vitamin D binding protein affects the correlation of 25(OH)D and frailty in the older men,” International Journal of Endocrinology, vol. 2014, Article ID 543783, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Speeckaert, G. Huang, J. R. Delanghe, and Y. E. C. Taes, “Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism,” Clinica Chimica Acta, vol. 372, no. 1-2, pp. 33–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Robien, L. M. Butler, R. Wang et al., “Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore,” British Journal of Nutrition, vol. 109, no. 3, pp. 493–502, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. D. Engelman, T. E. Fingerlin, C. D. Langefeld et al., “Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in hispanic and African Americans,” The Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 9, pp. 3381–3388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Braun, A. Kofler, S. Morawietz, and H. Cleve, “Sequence and organization of the human vitamin D-binding protein gene,” Biochimica et Biophysica Acta, vol. 1216, no. 3, pp. 385–394, 1993. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Braun, R. Bichlmaier, and H. Cleve, “Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types,” Human Genetics, vol. 89, no. 4, pp. 401–406, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Colston and C. M. Hansen, “Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer,” Endocrine-Related Cancer, vol. 9, no. 1, pp. 45–59, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. K. A. Tantisira, “Vitamin D: genetics and genomic effects,” in Vitamin D and Lung: Mechanisms and Disease Associations, A. A. Litonjua, Ed., vol. 3 of Respiratory Medicine, pp. 151–178, Springer Science & Business Media, 2012. View at Publisher · View at Google Scholar
  16. S. Rocchiccioli, G. Pelosi, S. Rosini et al., “Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression,” Journal of Translational Medicine, vol. 11, article 260, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Wang, Y. Li, L. Li et al., “Association of the vitamin D binding protein polymorphisms with the risk of type 2 diabetes mellitus: a meta-analysis,” British Medical Journal Open, vol. 4, no. 11, Article ID e005617, 2014. View at Publisher · View at Google Scholar
  18. D. Blanton, Z. Han, L. Bierschenk et al., “Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes,” Diabetes, vol. 60, no. 10, pp. 2566–2570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. F. Huang, K. Kurpinski, Q. Fang, R. J. Lee, and S. Li, “Proteomic identification of biomarkers of vascular injury,” American Journal of Translational Research, vol. 3, no. 2, pp. 139–148, 2011. View at Google Scholar · View at Scopus
  20. P. T. Gomme and J. Bertolini, “Therapeutic potential of vitamin D-binding protein,” Trends in Biotechnology, vol. 22, no. 7, pp. 340–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. U. Meier, O. Gressner, F. Lammert, and A. M. Gressner, “Gc-globulin: roles in response to injury,” Clinical Chemistry, vol. 52, no. 7, pp. 1247–1253, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. White and N. Cooke, “The multifunctional properties and characteristics of vitamin D-binding protein,” Trends in Endocrinology and Metabolism, vol. 11, no. 8, pp. 320–327, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. W. M. Lee and R. M. Galbraith, “The extracellular actin-scavenger system and actin toxicity,” The New England Journal of Medicine, vol. 326, no. 20, pp. 1335–1341, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. M.-A. Raymond, A. Désormeaux, A. Labelle et al., “Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor,” Biochemical and Biophysical Research Communications, vol. 338, no. 3, pp. 1374–1382, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Gasparri, A. Curcio, D. Torella et al., “Proteomics reveals high levels of vitamin D binding protein in myocardial infarction,” Frontiers in Bioscience (Elite Edition), vol. 2, no. 3, pp. 796–804, 2010. View at Google Scholar · View at Scopus
  26. P. Tuohimaa, “Vitamin D and aging,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 114, no. 1-2, pp. 78–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Corbi, A. Bianco, V. Turchiarelli et al., “Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on sirtuins,” International Journal of Molecular Sciences, vol. 14, no. 6, pp. 12696–12713, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Halpern, M. C. Mancini, M. E. C. Magalhães et al., “Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment,” Diabetology and Metabolic Syndrome, vol. 2, article 55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Łukasiewicz, M. Chodorowska, and I. Jakubowska, “Obesity as a factor in the development of cancer in type 2 diabetes,” Polski Merkuriusz Lekarski, vol. 38, no. 225, pp. 135–139, 2015. View at Google Scholar · View at Scopus
  30. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar
  31. W. A. Stini, “Sex differences in bone loss -an evolutionary perspective on a clinical problem,” Collegium Antropologicum, vol. 27, no. 1, pp. 23–46, 2003. View at Google Scholar · View at Scopus
  32. N. Yamamoto and S. Homma, “Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 19, pp. 8539–8543, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. M. I. Kamboh and R. E. Ferrell, “Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations,” Human Genetics, vol. 72, no. 4, pp. 281–293, 1986. View at Publisher · View at Google Scholar · View at Scopus
  34. A. L. Lauridsen, P. Vestergaard, and E. Nexo, “Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women,” Clinical Chemistry, vol. 47, no. 4, pp. 753–756, 2001. View at Google Scholar · View at Scopus
  35. A. L. Lauridsen, P. Vestergaard, A. P. Hermann et al., “Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595—early postmenopausal women,” Calcified Tissue International, vol. 77, no. 1, pp. 15–22, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Arnaud and J. Constans, “Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP),” Human Genetics, vol. 92, no. 2, pp. 183–188, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Abbas, J. Linseisen, T. Slanger et al., “The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status,” Cancer Epidemiology Biomarkers & Prevention, vol. 17, no. 6, pp. 1339–1343, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. V. M. Dardé, F. de la Cuesta, F. G. Dones, G. Alvarez-Llamas, M. G. Barderas, and F. Vivanco, “Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients?” Journal of Proteome Research, vol. 9, no. 9, pp. 4420–4432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Rocchiccioli, M. G. Andreassi, A. Cecchettini, C. Carpeggiani, A. L'Abbate, and L. Citti, “Correlation between vitamin D binding protein expression and angiographic-proven coronary artery disease,” Coronary Artery Disease, vol. 23, no. 7, pp. 426–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Jaimungal, K. Wehmeier, A. D. Mooradian, and M. J. Haas, “The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis,” Nutrition Research, vol. 31, no. 11, pp. 805–812, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. E. Feig, B. Hewing, J. D. Smith, S. L. Hazen, and E. A. Fisher, “High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies,” Circulation Research, vol. 114, no. 1, pp. 205–213, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. F. Feitosa, M. K. Wojczynski, R. Straka et al., “Genetic analysis of long-lived families reveals novel variants influencing high density-lipoprotein cholesterol,” Frontiers in Genetics, vol. 5, article 159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. R. W. Browne, B. Weinstock-Guttman, R. Zivadinov et al., “Serum lipoprotein composition and vitamin D metabolite levels in clinically isolated syndromes: results from a multi-center study,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 143, pp. 424–433, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Hirschler, G. Maccallini, C. Molinari et al., “Association between vitamin D and Apo B concentrations in Argentinean Indian children,” Clinica Chimica Acta, vol. 429, pp. 147–151, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Mursu, T. Nurmi, S. Voutilainen, T.-P. Tuomainen, and J. K. Virtanen, “The association between serum 25-hydroxyvitamin D3 concentration and risk of disease death in men: modification by magnesium intake,” European Journal of Epidemiology, vol. 30, no. 4, pp. 343–347, 2015. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Napolioni, P. Giannì, F. M. Carpi, I. M. Predazzi, and N. Lucarini, “APOE haplotypes are associated with human longevity in a Central Italy population: evidence for epistasis with HP 1/2 polymorphism,” Clinica Chimica Acta, vol. 412, no. 19-20, pp. 1821–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Bonomini, F. Filippini, T. Hayek et al., “Apolipoprotein E and its role in aging and survival,” Experimental Gerontology, vol. 45, no. 2, pp. 149–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Wong, W. H. Lim, J. Lewis et al., “Vitamin D and cancer mortality in elderly women,” BMC Cancer, vol. 15, article 106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Fujioka, Y. Suzuki, T. Okamoto, N. Mastushita, M. Hasegawa, and S. Omori, “Prevention of renal cell carcinoma by active vitamin D3,” World Journal of Surgery, vol. 24, no. 10, pp. 1205–1210, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. A. M. Mondul, S. J. Weinstein, K. A. Moy, S. Männistö, and D. Albanes, “Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma,” International Journal of Cancer, vol. 134, no. 11, pp. 2699–2706, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. S. J. Weinstein, R. Z. Stolzenberg-Solomon, W. Kopp, H. Rager, J. Virtamo, and D. Albanes, “Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin d and pancreatic cancer risk: a nested case-control study,” Cancer Research, vol. 72, no. 5, pp. 1190–1198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Jorde, H. Schirmer, T. Wilsgaard et al., “The DBP phenotype Gc-1f/Gc-1f is associated with reduced risk of cancer. The tromsø study,” PLoS ONE, vol. 10, no. 5, Article ID e0126359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  53. T. Shao, P. Klein, and M. L. Grossbard, “Vitamin D and breast cancer,” The Oncologist, vol. 17, no. 1, pp. 36–45, 2012. View at Publisher · View at Google Scholar
  54. S. J. Weinstein, A. M. Mondul, W. Kopp, H. Rager, J. Virtamo, and D. Albanes, “Circulating 25-hydroxyvitamin D, vitamin D-binding protein and risk of prostate cancer,” International Journal of Cancer, vol. 132, no. 12, pp. 2940–2947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Banu, “Causes, consequences, and treatment of osteoporosis in men,” Drug Design, Development and Therapy, vol. 7, pp. 849–860, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. M. T. Drake, “Osteoporosis and cancer,” Current Osteoporosis Reports, vol. 11, no. 3, pp. 163–170, 2013. View at Publisher · View at Google Scholar
  57. I. Marech, A. Vacca, G. Ranieri, A. Gnoni, and F. Dammacco, “Novel strategies in the treatment of castration-resistant prostate cancer (Review),” International Journal of Oncology, vol. 40, no. 5, pp. 1313–1320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. A. L. Lauridsen, P. Vestergaard, A. P. Hermann, H. J. Moller, L. Mosekilde, and E. Nexo, “Female premenopausal fracture risk is associated with Gc phenotype,” Journal of Bone and Mineral Research, vol. 19, no. 6, pp. 875–881, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Yamamoto, H. Suyama, and N. Yamamoto, “Immunotherapy for prostate cancer with Gc protein-derived macrophage-activating factor, GcMAF,” Translational Oncology, vol. 1, no. 2, pp. 65–72, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. N. Yamamoto and R. Kumashiro, “Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells,” Journal of Immunology, vol. 151, no. 5, pp. 2794–2802, 1993. View at Google Scholar · View at Scopus
  61. Y. Fang, J. B. J. Van Meurs, P. Arp et al., “Vitamin D binding protein genotype and osteoporosis,” Calcified Tissue International, vol. 85, no. 2, pp. 85–93, 2009. View at Publisher · View at Google Scholar · View at Scopus